CAPGEMINI overview

Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing inflammation to optimize health, announced dosing of the first patient in the PRIME ( PR econditioning IM munostimulatory E valuation) Phase 1b clinical study of intravenous single ascending doses of Gemini in patients with Stage 3 and 4 Chronic Kidney Disease (CKD). The US-based, multi-site, placebo-controlled study will enroll up to forty...

Salesforce and Google today announced a major expansion of their strategic partnership, delivering choice in the models and capabilities businesses use to build and deploy AI-powered agents . In today's constantly evolving AI landscape, innovations like autonomous agents are emerging so quickly that businesses struggle to keep pace. This expanded partnership provides crucial flexibility, empowering customers to develop tailored AI solutions that meet their specific needs, rather than being...

App Orchid, a Google Cloud Cortex Framework partner, will enable customers to ask natural language questions and get AI-powered insights from enterprise data grounded with Cortex Framework SAN RAMON, CA / ACCESS Newswire / February 5, 2025 / App Orchid , a leader in making data actionable with Artificial Intelligence (AI), today announced that it has expanded its collaboration with Google Cloud to provide supporting Google Cloud Cortex Framework deployments, accelerating business decisions and...

Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the treatment of disease, announced today that it has started its PRIME ( PR econditioning IM munostimulatory E valuation) Phase 1b clinical study of escalating doses of intravenously administered Gemini in patients with Stage 3 and 4 Chronic Kidney Disease (CKD). The US based multi-site placebo-controlled...

TCL Brings Next-gen Google TVs with Gemini Model to CES 2025 PR Newswire SHENZHEN, China, Jan. 16, 2025 SHENZHEN, China , Jan. 16, 2025 /PRNewswire/ -- TCL Electronics, a leading consumer electronics brand and the world's top two TV brand, announced at CES 2025 that it is deepening its partnership with Google TV and will launch all-new Google TVs with Gemini capabilities in 2025, promising to transform home entertainment with immersive and intelligent features. With the Gemini model and new...

Toonsutra's Quest is to Bring the Best Comics & Webtoons Across all of India in Every Regional Language MUMBAI, IN / ACCESSWIRE / December 11, 2024 / Toonsutra, India's homegrown webtoon comic app , announced today that the Company was featured today in the Developer Showcase Carousel of Google's DeepMind website for its current prototyping with translation capabilities of Gemini 2.0 Flash (currently available in experimental preview only) to make their vast library of comics accessible to a...

Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the treatment of disease, announced today that the United States Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for Gemini . This game changing milestone allows the Company to initiate its US based Phase 1b clinical study to evaluate the potential of Gemini as a...